Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bruce M. Sprague is active.

Publication


Featured researches published by Bruce M. Sprague.


The Lancet | 2003

Adverse events associated with dietary supplements: an observational study

Mary E Palmer; Christine A. Haller; Patrick E. McKinney; Wendy Klein-Schwartz; Anne Tschirgi; Susan C. Smolinske; Alan Woolf; Bruce M. Sprague; Richard Ko; Gary Everson; Lewis S. Nelson; Teresa Dodd-Butera; W Dana Bartlett; Brian R. Landzberg

BACKGROUND Adverse events associated with dietary supplements are difficult to monitor in the USA, because such products are not registered before sale, and there is little information about their content and safety. METHODS In 1998, 11 poison control centres in the USA recorded details of 2332 telephone calls about 1466 ingestions of dietary supplements, in 784 of which patients had symptoms. We used a multitiered review process (kappa 0.42) to select 489 cases for whom we were at least 50% certain that their negative events were associated with dietary supplements. We aimed to assess the effects of multiple ingredients and long-term use, and collated data for patterns of use and information resources. FINDINGS A third of events were of greater than mild severity. We noted both new and previously reported associations that included myocardial infarction, liver failure, bleeding, seizures, and death. Increased symptom severity was associated with use of several ingredients, long-term use, and age. Paediatric exposures were more often unintentional than were adult ingestions, and treatment of disease was the reason for supplement use in at least 28% of reports. Most products and ingredients were not identified in the information database (Poisindex) used by poison control centres, and specific adverse events were reported variably among five additional sources. INTERPRETATION Dietary supplements are associated with adverse events that include all levels of severity, organ systems, and age groups. Associations between adverse events and ingredients are difficult to verify if a product has more than one ingredient, and because of incomplete information systems. Research into hazards and risks of dietary supplements should be a priority.


Journal of Translational Medicine | 2012

Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury

Derrick E. Fouts; Rembert Pieper; Sebastian Szpakowski; Hans G. Pohl; Susan Knoblach; Moo-Jin Suh; Shih-Ting Huang; Inger Ljungberg; Bruce M. Sprague; Sarah Lucas; Manolito Torralba; Karen E. Nelson; Suzanne L. Groah

BackgroundClinical dogma is that healthy urine is sterile and the presence of bacteria with an inflammatory response is indicative of urinary tract infection (UTI). Asymptomatic bacteriuria (ABU) represents the state in which bacteria are present but the inflammatory response is negligible. Differentiating ABU from UTI is diagnostically challenging, but critical because overtreatment of ABU can perpetuate antimicrobial resistance while undertreatment of UTI can result in increased morbidity and mortality. In this study, we describe key characteristics of the healthy and ABU urine microbiomes utilizing 16S rRNA gene (16S rDNA) sequencing and metaproteomics, with the future goal of utilizing this information to personalize the treatment of UTI based on key individual characteristics.MethodsA cross-sectional study of 26 healthy controls and 27 healthy subjects at risk for ABU due to spinal cord injury-related neuropathic bladder (NB) was conducted. Of the 27 subjects with NB, 8 voided normally, 8 utilized intermittent catheterization, and 11 utilized indwelling Foley urethral catheterization for bladder drainage. Urine was obtained by clean catch in voiders, or directly from the catheter in subjects utilizing catheters. Urinalysis, urine culture and 16S rDNA sequencing were performed on all samples, with metaproteomic analysis performed on a subsample.ResultsA total of 589454 quality-filtered 16S rDNA sequence reads were processed through a NextGen 16S rDNA analysis pipeline. Urine microbiomes differ by normal bladder function vs. NB, gender, type of bladder catheter utilized, and duration of NB. The top ten bacterial taxa showing the most relative abundance and change among samples were Lactobacillales, Enterobacteriales, Actinomycetales, Bacillales, Clostridiales, Bacteroidales, Burkholderiales, Pseudomonadales, Bifidobacteriales and Coriobacteriales. Metaproteomics confirmed the 16S rDNA results, and functional human protein-pathogen interactions were noted in subjects where host defenses were initiated.ConclusionsCounter to clinical belief, healthy urine is not sterile. The healthy urine microbiome is characterized by a preponderance of Lactobacillales in women and Corynebacterium in men. The presence and duration of NB and method of urinary catheterization alter the healthy urine microbiome. An integrated approach of 16S rDNA sequencing with metaproteomics improves our understanding of healthy urine and facilitates a more personalized approach to prevention and treatment of infection.


Pediatric Critical Care Medicine | 2001

The costs associated with nosocomial bloodstream infections in the pediatric intensive care unit.

Anthony D. Slonim; Heather C. Kurtines; Bruce M. Sprague; Nalini Singh

Objective To assess the operational and subsidiary costs and length of stay (LOS) attributable to nosocomial bloodstream infections (BSI) in a pediatric intensive care unit (PICU). Design Matched case-control study. Setting Sixteen bed PICU in a 250-bed tertiary-care pediatric hospital. Patients Cases with BSI were prospectively identified from PICU patients who developed a nosocomial BSI from August 1996 to July 1998. Controls were PICU patients who were matched for age, severity of illness, diagnosis, and admission date who did not develop a nosocomial BSI. Results A total of 38 cases and 38 controls form the basis for this study. The cases and controls were similar with respect to the matching criteria. In addition, the cases and controls did not differ with respect to demographic characteristics or PICU survival. There was a trend toward increased hospital mortality among cases (23.7% vs. 10.5%, p = .084). Significant differences were encountered in the utilization of PICU therapeutic modalities. Cases were significantly less likely to be managed care plan enrollees (36.8% vs. 60.5%, p = .043). Total operational and subsidiary costs for radiology, pharmacy, and laboratory services were significantly higher for cases than controls (


Pediatrics | 2015

Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring

Ron Keren; Nader Shaikh; Hans G. Pohl; Lisa Gravens-Mueller; Anastasia Ivanova; Lisa B. Zaoutis; Melissa Patel; Rachel deBerardinis; Allison Parker; Sonika Bhatnagar; Mary Ann Haralam; Marcia A. Pope; Diana H. Kearney; Bruce M. Sprague; Raquel Barrera; Bernarda Viteri; Martina Egigueron; Neha Shah; Alejandro Hoberman

78,272 vs.


Critical Care Medicine | 2000

Risk assessment and standardized nosocomial infection rate in critically ill children

Nalini Singh-Naz; Bruce M. Sprague; Kantilal M. Patel; Murray M. Pollack

35,005,


Journal of Pediatric Urology | 2011

Observation of infants with SFU grades 3-4 hydronephrosis: worsening drainage with serial diuresis renography indicates surgical intervention and helps prevent loss of renal function.

Sherry S. Ross; Steve Kardos; Aaron Krill; Jason Bourland; Bruce M. Sprague; Massoud Majd; Hans G. Pohl; M. David Gibbons; A. Barry Belman; H. Gil Rushton

3,622 vs.


Emerging Infectious Diseases | 2005

Characterizing vancomycin-resistant enterococci in neonatal intensive care.

C. Rebecca Sherer; Bruce M. Sprague; Joseph M. Campos; Sumathi Nambiar; Rachel Temple; Billie L. Short; Nalini Singh

1,432,


Pediatrics | 1999

Prognostication and certainty in the pediatric intensive care unit

James P. Marcin; Murray M. Pollack; Kantilal M. Patel; Bruce M. Sprague; Urs E. Ruttimann

8,635 vs.


Infection Control and Hospital Epidemiology | 2008

Molecular and Descriptive Epidemiology of Multidrug‐Resistant Enterobacteriaceae in Hospitalized Infants

Brian Anderson; Sarah Nicholas; Bruce M. Sprague; Joseph M. Campos; Billie L. Short; Nalini Singh

4,630, and


Pediatrics | 2005

Stable prevalence but changing risk factors for sudden infant death syndrome in child care settings in 2001

Rachel Y. Moon; Bruce M. Sprague; Kantilal M. Patel

8,648 vs.

Collaboration


Dive into the Bruce M. Sprague's collaboration.

Top Co-Authors

Avatar

Hans G. Pohl

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Nalini Singh

Children's National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Inger Ljungberg

MedStar National Rehabilitation Hospital

View shared research outputs
Top Co-Authors

Avatar

Massoud Majd

Children's National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Joseph M. Campos

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar

Kantilal M. Patel

Children's National Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Billie L. Short

George Washington University

View shared research outputs
Top Co-Authors

Avatar

H. Gil Rushton

Johns Hopkins University

View shared research outputs
Researchain Logo
Decentralizing Knowledge